American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

October 07, 2021

Newsletter Sponsor

[Technical Paper] The Effect of PVP Viscosity on the Binding Performance in Naproxen Tablets

Certain active ingredients can present flow and compactability challenges, requiring wet granulation to enable high-speed tableting. This study compares the performance of VIVAPHARM® PVP K25, VIVAPHARM® PVP K30, and VIVAPHARM® PVP K90, respectively, as wet-granulation binders in an immediate-release formulation of naproxen as the model API.

	Industry News

FDA Issues Guidance for Responsibilities of Safety Reporting and Safety Assessment in Research Studies
The US FDA has issued the draft guidance for industry, Investigator Responsibilities—Safety ... read more »

Dynavax and US DoD Announce Collaboration to Develop Adjuvanted Plague Vaccine
Dynavax has executed an agreement for approximately $22 million over two and a half years to develop... read more »

Atara Biotherapeutics and Pierre Fabre Collaborate to Commercialize Tabelecleucel
Atara Biotherapeutics and Pierre Fabre announced an exclusive commercialization agreement for ... read more »

Xencor and Janssen to Advance Plamotamab and XmAb CD28 Bispecific Antibody Combinations in B-Cell Malignancies
Xencor a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and ... read more »

	Infographic

5 Key Steps to a Successful Laboratory Relocation
20 instruments or 2,000? Across the hall or across the world? Moving a laboratory anywhere can be an extensive process. Worried you'll overlook an ... read more »

	Featured Articles

Quantification of Residual Host Cell DNA in Protamine Sulfate Drug Product Using Droplet Digital PCR Protamine Sulfate (ProS) is the only FDA approved anticoagulation reversal agent for unfractionated heparin. ProS is biologically derived from chum ... read more »

Pharmaceutical P.I.N. Points Patent Innovation News July/August 2021 Ayurvedic medicines attain/maintain harmony in the system and work on improving the health of the body rather than treating symptoms. The patent ... read more »

	Featured Video

On-Demand Webinar: Validation of a Mycoplasma NAT Platform for Product Release in Cell Therapy
This webinar will provide a review of validation strategies and implementation for a rapid at-line mycoplasma test for cell therapy companies. watch »

On-Demand Webinar: Unified Particle Analysis by Raman and Infrared Microscopy
In this webinar you’ll learn: Identification of unknown particles in a wide variety of manufacturing processes. Reverse engineering and failure ... watch »

	Featured Products

Sievers M9 TOC Analyzers
read more »

	Featured Whitepaper

eBook: Pyrogen Detection Strategies
A pyrogen is, by definition, a substance that produces a rise in temperature in a human or animal. Pyrogens constitute a heterogeneous group of contaminants comprising microbial and non-microbial ... read more »

	Events

Ophthalmic Drugs Conference
London, UK – 11/22/2021
The global ophthalmic drug market is forecast to surpass $60 billion USD by 2025 with increasing focus from the industry on alternative delivery ... event details »

Medical Wearables for Biosensors USA Conference 2021
Boston, MA – 10/25/2021
Exploring therapeutic applications of connected on-body devices The global wearable biosensors market is a rapidly expanding industry with ... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA